Teva Pharmaceutical Industries Ltd. (TEVA)
Teva Pharmaceutical Industries Market Cap : 49.68B for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 49.68B |
| November 13, 2026 | 51.93B |
| November 12, 2026 | 50.94B |
| November 11, 2026 | 50.46B |
| November 10, 2026 | 49.48B |
| November 09, 2026 | 50.15B |
| November 06, 2026 | 49.73B |
| November 05, 2026 | 48.76B |
| November 04, 2026 | 48.84B |
| November 03, 2026 | 48.91B |
| November 02, 2026 | 47.50B |
| October 30, 2026 | 49.03B |
| October 29, 2026 | 48.31B |
| October 28, 2026 | 46.57B |
| October 27, 2026 | 47.05B |
| October 26, 2026 | 46.54B |
| October 23, 2026 | 45.91B |
| October 22, 2026 | 46.84B |
| October 21, 2026 | 47.32B |
| October 20, 2026 | 47.59B |
| October 19, 2026 | 48.13B |
| October 16, 2026 | 48.35B |
| October 15, 2026 | 47.89B |
| October 14, 2026 | 47.44B |
| October 13, 2026 | 48.06B |
| Date | Value |
|---|---|
| October 12, 2026 | 47.96B |
| October 09, 2026 | 47.88B |
| October 08, 2026 | 45.73B |
| October 07, 2026 | 45.64B |
| October 06, 2026 | 45.59B |
| October 05, 2026 | 46.20B |
| October 02, 2026 | 46.05B |
| October 01, 2026 | 45.80B |
| September 30, 2026 | 46.13B |
| September 29, 2026 | 46.38B |
| September 28, 2026 | 45.30B |
| September 25, 2026 | 45.66B |
| September 24, 2026 | 46.86B |
| September 23, 2026 | 45.45B |
| September 22, 2026 | 46.04B |
| September 21, 2026 | 46.67B |
| September 18, 2026 | 45.41B |
| September 17, 2026 | 45.66B |
| September 16, 2026 | 44.89B |
| September 15, 2026 | 45.73B |
| September 14, 2026 | 45.11B |
| September 11, 2026 | 43.10B |
| September 10, 2026 | 42.35B |
| September 09, 2026 | 42.93B |
| September 08, 2026 | 42.83B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Merck & Co., Inc. | 356.35B |
| Bristol Myers Squibb Co. | 128.63B |
| Eli Lilly & Co. | 1.347T |
| Pfizer Inc. | 164.50B |
| Sanofi | 117.50B |
Market Cap Related Metrics
| PE Ratio | 102.26 |
| PS Ratio | 2.892 |
| Price to Book Value | 6.226 |
| Price to Free Cash Flow | 40.80 |
| Price | 42.57 |
| Earnings Yield | 0.98% |
| Operating PE Ratio | 15.11 |
| Normalized PE Ratio | 27.06 |